Soo In Kim
Inventor
Stats
- 4 US patents issued
- 11 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 4 US Patents Issued
- 11 US Applications Filed
- 44 Total Citation Count
- Jun 1, 2010 Most Recent Filing
- Dec 2, 1999 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| ASTRIUM LIMITED | 1
| 2008
|
| ALLOFERON, INC. | 1
2 2 | 1999
2000 2003 |
| Jenquest | 2
| 2000
|
| MOGAM BIOTECHNOLOGY RESEARCH INSTITUTE | 2
1 2 1 2 | 2006
2007 2008 2009 2010 |
| LEHIGH VALLEY TECHNOLOGIES, INC. | 2
| 2003
|
Inventor Addresses
| Address | Duration |
|---|---|
| 1-901, Hangang Apt., Jamwon-Dong, Seochio-ku, Seoul, KR | Jan 08, 02 - Jan 08, 02 |
| Kyonggi-do, KR | Dec 24, 09 - Dec 24, 09 |
| Seoul, KR | Feb 07, 02 - Dec 09, 08 |
| Yongin-city, KR | Mar 11, 10 - Mar 11, 10 |
| Yongin-si, KR | Aug 19, 10 - Nov 27, 12 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 10 |
| A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 4 |
| C07H: | SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS | 6 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 8318199 | 2012 | Liposome for liver-specific delivery and release of therapeutic nucleic acids or drugs | 1 |
| 2011/0008,885 | 2011 | LINEAR DOUBLE-STRANDED RNA MOLECULE INTERFERING WITH DIFFERENT TARGET GENES | 2 |
| 2010/0239,657 | 2010 | COMPOSITE FOR LIVER-SPECIFIC DELIVERY AND RELEASE OF THERAPEUTIC NUCLEIC ACIDS OR DRUGS | 7 |
| 2010/0209,491 | 2010 | METHOD FOR ENHANCING SERUM STABILITY AND LOWERING IMMUNE RESPONSE OF SIRNA DOWN-REGULATING GENE EXPRESSION OF HBV OR HCV | 4 |
| 2010/0063,132 | 2010 | SMALL INTERFERING RNA AND PHARMACEUTICAL COMPOSITION FOR TREATMENT OF HEPATITIS B COMPRISING THE SAME | 13 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.